e-learning
resources
Virtual 2020
Pre-Congress Content
Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Homozygous mutations of ARFGAP1 gene in severe sarcoidosis
T. EL JAMMAL (Lyon, France), A. Calender (Lyon, France), P. Sève (Lyon, France), Y. Pachéco (Lyon, France)
Source:
Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Session:
Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Session type:
E-poster session
Number:
1075
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. EL JAMMAL (Lyon, France), A. Calender (Lyon, France), P. Sève (Lyon, France), Y. Pachéco (Lyon, France). Homozygous mutations of ARFGAP1 gene in severe sarcoidosis. 1075
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis
Source: Eur Respir J 2015; 46: 474-485
Year: 2015
First heterozygous
NOP10
mutation in familial pulmonary fibrosis
Source: Eur Respir J, 55 (6) 1902465; 10.1183/13993003.02465-2019
Year: 2020
Sarcoidosis is associated with a truncating splice site mutation in the
BTNL2
gene
Source: Eur Respir J 2005; 26: Suppl. 49, 468s
Year: 2005
Bi-allelic missense
ABCA3
mutations in a patient with childhood ILD who reached adulthood
Source: ERJ Open Res, 5 (3) 00066-2019; 10.1183/23120541.00066-2019
Year: 2019
Pulmonary fibrosis in non-mutation carriers of families with short telomere syndrome gene mutations.
Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis
Year: 2021
Phenotype characterisation of
TBX4
mutation and deletion carriers with neonatal and paediatric pulmonary hypertension
Source: Eur Respir J, 54 (2) 1801965; 10.1183/13993003.01965-2018
Year: 2019
Variable phenotype associated with SP-C gene mutations: fatal case with the I73T mutation
Source: Eur Respir J 2004; 24: 1072-1073
Year: 2004
Familial interstitial lung disease and ABCA3 gene Gly964Asp mutation
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Homozygous variant rs2076530 of BTNL2 and familial sarcoidosis: analysis of 5 members of a family
Source: Annual Congress 2007 - Novel genetic markers in pathology
Year: 2007
Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required?
Source: Eur Respir J 2014; 44: 269-270
Year: 2014
Pulmonary fibrosis associated with TINF2 gene mutation: is somatic reversion required?
Source: Eur Respir J 2014; 44: 270-271
Year: 2014
First identified “severe” mutations and extended rearrangements in the CFTR gene in Russian cystic fibrosis patients
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020
Mutations in SFTPC, SFTPA2 and TERT explain 60% of familial pulmonary fibrosis and correlate to specific disease phenotypes
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
Progressive lung disease caused by ABCA3 mutation
Source: Virtual Congress 2020 – From the bronchoscope to the clinic: paediatric bronchology at a glance
Year: 2020
Phenotype and outcome of PAH patients carrying a TBX4 mutation
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020
Evaluation of
MRP1-5
gene expression in cystic fibrosis patients homozygous for the ΔF508 mutation
Source: Annual Congress 2003 - Cystic fibrosis: new genes, new controversies
Year: 2003
Novel mutations in the folliculin gene associated with spontaneous pneumothorax
Source: Eur Respir J 2008; 32: 1316-1320
Year: 2008
Rescue of CFTR function impaired by mutations in exon 15
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020
A new SERPINA-1 missense mutation associated with alpha-1 antitrypsin deficiency and bronchiectasis.
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017
Sftpc mutations are a common cause of adult familial idiopathic interstitial pneumonia
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept